Patents Assigned to Women's Lab Company, LLC
  • Patent number: 8629120
    Abstract: A method of treating a human to reduce the risk of malignancies or limit the spread of malignancies includes administering an FMR1 inhibitor to the human to block expression of an FMR1 gene. The FMR1 inhibitor blocks FMR1 genes in the human with at least one of two alleles with less than 26 triple CGG repeats.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: January 14, 2014
    Assignee: Women's Lab Company, LLC
    Inventors: Norbert Gleicher, David H Barad